1[1]Neuhaus P,Jonas S,Bechstein WO,et al .Liver transplantation for hepato cellular carcinoma.Transplant Proc ,1999,31:469-71.
2[2]Ringe B,Wittekind C,Bechstein WO,et al. The role of liver transplantat ion in hepatobiliary malignancy.Ann Surg,1989,209:88-93.
3[3]Pann I.Hepatic transplantation for primary and metastatic cancersof li ver.Surgery,1991,110:726-734.
4[4]Lau WY,Leung TW,Ho SK,et al.Adijvant intra-arterial iodine-131-laba lle d lipiodol for resectable hepatocellular carcinoma:a prospective randomized tria l.Lancet ,1999,353:797-801.
6[6]Mazzaferro V,Regalia E,Doci R,et al.Livr transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl M ed,1996,334:693-699.
7[7]Mor E,Kaspa RT,Sheiner P,et al.Treatment of hepatocellular carcino ma associated with cirrhosis in the era of liver transplantation.Ann In tern Med,1998,129:643-53.
8[8]Llovet JM,Bruix J,Gores GJ.Surgical resection versus transplantation f or early hepatocellular carcinoma:clues for the best strategy.Hepatolog y,2000,31:1019-21.
9[9]Esquivel CO,Keeffe EB,Garcia G,et al.Resection versus transplantation for hepatocellular carcinoma.J Gastroenterol Hepatol,1999,14 S uppl:37-41.
6Arroyo V,Gines P,Gerbes AL,et al. Definition and cliagnostic Criteria of refractory ascites and Hepatorenal Syndrom in cirrhosis. Hepatology, 1996,23 ( 1 ) :164.
7Moser MA. Options for induction immunosuppression in liver transplant recipients. Drugs,2002,62 ( 7 ) : 995.
8Torres A, Ewig S, Insansti J, et al. Etiology and microbial patterns of pulmonary infdtrates in patients with orthotopic liver transplantation. Chest, 2000,117 (4) :494.
9Rabkin JM,Oroloff SL,Corless CL,et al. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg,2000,179(5) :426.
10Stephenson GR, Moretti EW, Moalem HE, et al. Malnutrition in liver transplant patients. Transplantation,2001,72(4) :666.
